| Report Date | |
| Manager | |
| Fund Name | |
| Strategy | |
| Latest Return Date | |
| Latest Return | |
| Latest 6 Months | |
| Latest 12 Months | |
| Latest 24 Months | |
| Annualised Since Inception | |
| Inception Date | |
| FUM (millions) | |
| Fund Overview | |
| Manager Comments | The Manager comments 'Despite the weaker US data, rising geopolitical tensions in the Ukraine and some economic uncertainties in China, markets chose to look through it all, seemingly comfortable in the belief that central banks around the world will come to the rescue again if necessary. The Fund's unit price increased by 2.4% in February. The solid performance was fairly broadly based across the portfolio, with the biggest positive contributions coming from our holdings in Reckitt Benckiser, BAT, GlaxoSmithKline, BSkyB and DirecTV. Small negative contributions came from Comcast, Safran and Zimmer Holdings. The Fund continues to have no foreign currency hedging in place.' |
| More Information | » View detailed profile of this fund |
